Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Jason M. Cota"'
Autor:
Jason M Cota, Taylor M Benavides, John D Fields, Nathan Jansen, Anuradha Ganesan, Rhonda E Colombo, Jason M Blaylock, Ryan C Maves, Brian K Agan, Jason F Okulicz
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0250607 (2021)
ObjectivesWe sought to determine the prevalence of phosphodiesterase type 5 inhibitor (PDE-5) mediated drug-drug interactions (DDIs) in males with HIV infection receiving antiretroviral therapy (ART) and identify factors associated with PDE-5-mediate
Externí odkaz:
https://doaj.org/article/b77ac608004b4c3eb908b71015873297
Publikováno v:
Current Fungal Infection Reports. 14:258-267
Clinicians should be encouraged to use pharmacokinetic-pharmacodynamic (PK-PD) studies to optimize antifungal drug dosing in the absence of robust comparative effectiveness data or in cases where evidence of causality has not yet been firmly establis
Publikováno v:
Infection and Drug Resistance, Vol 2008, Iss default, Pp 63-77 (2009)
Nathan P Wiederhold1, Jason M Cota2, Christopher R Frei11University of Texas at Austin College of Pharmacy, Austin, Texas, USA; 2University of the Incarnate Word Feik School of Pharmacy, San Antonio, Texas, USAAbstract: Micafungin is an echinocandin
Externí odkaz:
https://doaj.org/article/55f7053ecbe94b5c93a90bb95a912582
Autor:
Jason M. Cota, Thankam Sunil, Jason F. Okulicz, Colton Daniels, Xiaohe Xu, Brian K. Agan, Anuradha Ganesan, Nathan K Jansen
Publikováno v:
HIV medicineReferences. 22(7)
HIV infection is associated with increased risk of erectile dysfunction (ED); however, factors associated with ED remain unclear. We evaluated the prevalence of ED among men living with HIV and factors associated with ED diagnosis in the US Military
Autor:
Jason M. Cota, Taylor M. Benavides
Publikováno v:
Side Effects of Drugs Annual ISBN: 9780128203309
Appraisal of available literature published from January 2019 to April 2020 yielded a total of 98 studies, 14 of which pertained to aminoglycosides, 26 to fluoroquinolones, 23 to glycopeptides, 3 to clindamycin, 13 to macrolides, 7 to oxazolidinones,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04d86aac2acec9f8e90081b0187c8622
https://doi.org/10.1016/bs.seda.2020.09.008
https://doi.org/10.1016/bs.seda.2020.09.008
Autor:
Jason M. Cota, Kathleen A. Lusk, Merlyn Joseph, Cheryl Horlen, Rebecca L. Attridge, Rebecca L. Brady, Russell T. Attridge
Publikováno v:
Hosp Pharm
Background: Fluconazole-associated liver injury is estimated to occur in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31d10d7dde2d254b6de15e035a915195
https://europepmc.org/articles/PMC6852028/
https://europepmc.org/articles/PMC6852028/
Publikováno v:
Journal of pharmacy practice. 32(4)
Objective: To review the efficacy of cefepime for use in infections caused by extended-spectrum beta-lactamase (ESBL)-producing organisms. Data Sources: A PubMed literature search (May 2000 to June 2017) was performed using the keyword cefepime and t
Autor:
Xiaohe Xu, Robert Deiss, Colton Daniels, Thankam Sunil, Anuradha Ganesan, Nathan K Jansen, Morgan Byrne, Brian K. Agan, Jason F. Okulicz, Jason M. Cota
Publikováno v:
Open Forum Infectious Diseases
Background HIV-infected men have increased incidence of erectile dysfunction (ED) compared with men without HIV infection. Risk factors for ED among HIV-positive individuals have not been widely described. Methods A retrospective cohort study was com
Publikováno v:
Current Fungal Infection Reports. 7:89-95
The echinocandins target fungi by inhibiting the production of (1,3)-β-d-glucan, an essential component of the fungal cell wall. These agents have less toxicity to mammalian cells, as compared to other antifungals; however, they maintain potent acti
Autor:
Kevin K. Chung, Jason M. Cota, Matthew P. Rowan, Clinton K. Murray, Kevin S. Akers, Alireza FakhriRavari
Publikováno v:
Clinical therapeutics. 38(9)
Purpose Despite advances in the care of patients with severe burn injury, infection-related morbidity and mortality remain high and can potentially be reduced with antimicrobial dosing optimized for the infecting pathogen. However, anti-infective dos